<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>/<z:mpath ids='MPATH_336'>leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>/L) is a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> disease with respect to epidemiological patterns and cell origin </plain></SENT>
<SENT sid="1" pm="."><plain>The occurrence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>/L with an immature phenotype raises the question whether this phenotype might be a consequence of early B-cell transformation or, alternatively, a secondary feature of transformed, mature B cells </plain></SENT>
<SENT sid="2" pm="."><plain>It also poses important clinical questions regarding diagnosis and therapeutic procedures </plain></SENT>
<SENT sid="3" pm="."><plain>Here we describe the case of a 4-yr-old child with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>/L and <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">FAB L3</z:e> <z:mp ids='MP_0000002'>morphology</z:mp>, with phenotypic and genotypic characteristics of a CD10+ precursor B-cell <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoid <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (ALL) associated with t(8;14)(q24;q32) </plain></SENT>
<SENT sid="4" pm="."><plain>Molecular analysis showed expression of RAG1 and RAG2 and an unmutated VDJCmu immunoglobulin rearrangement coinciding with a lack of AICDA expression, indicating an immature B-cell origin </plain></SENT>
<SENT sid="5" pm="."><plain>His clinical response suggested that <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">FAB L3</z:e> ALL with MYC rearrangement and an aberrant precursor B-<z:mp ids='MP_0005384'>cell phenotype</z:mp> is clinically similar to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>/L </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, short, intensive chemotherapeutic protocols seemed to be beneficial </plain></SENT>
<SENT sid="7" pm="."><plain>This case also allowed us to refine the description of cellular and molecular variants of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>/L regarding the cell origin and pathogenesis of this biologically <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> disease </plain></SENT>
</text></document>